Inhibitory Effect of Curcumin, Chlorogenic Acid, Caffeic Acid, and Ferulic Acid on Tumor Promotion in Mouse Skin by 12-O-Tetradecanoylphorbol-13-Acetate

Cancer Research

Volumn 48, Issue 21, 1988, Pages 5941-5946

  Huang, Mou Tuan ^a   Smart, Robert C ^b   Wong, Ching Quo ^c   Conney, Allan H ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID; CHLOROGENIC ACID; CURCUMIN; FERULIC ACID; PHORBOL ESTER; RETINOIC ACID;

ANIMAL EXPERIMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TOPICAL DRUG ADMINISTRATION; TUMOR PROMOTION INHIBITOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CAFFEIC ACIDS; CATECHOLS; CHLOROGENIC ACID; CINNAMATES; COUMARIC ACIDS; CURCUMIN; DNA; EDEMA; FEMALE; MICE; ORNITHINE DECARBOXYLASE; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 0023790908     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Chopra, R. V., Chopra, I. C., Handa, K. L., and Kapur. L. D. In: Indigenous Drugs of India, Ed. 2, pp. 325-327. Calcutta: Dhur, 1958.
2. Nadkarn, K. M. Curcuma longa. In: K. M. Nadkami (ed.), India Materia Medica, pp. 414-416. Bombay: Popular Prakashan Publishing Co., 1976.
3. Wealth of India. In: Raw Materials, p. 402. New Delhi: CSIR, 1950.
4. Bacon, E. Health protection branch regulation of food additives. Can. Pharm. J., 112: 340-344, 1979.
5. Marmion, D. M. Colorants exempt from certification. In: Handbook of U.S. Colorants for Food, Drugs and Cosmetics, pp. 86-87. New York: John Wiley & Sons, 1979.
6. Govindarajan, V. S. Turmeric-chemistry, technology and quality. CRC Crit. Rev. Food Sci. Nutr., 12: 199-301, 1980.
7. Schwarz, J. A., Viaje, A., and Slaga, T. J. Flucinolone acetonide: A potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem. Biol. Interact., 17: 331-347, 1977.
8. Slaga, T. J., and Scribner, J. D. Brief communication: Inhibition of tumor initiation and promotion by anti-inflammatory agents. J. Natl. Cancer Inst., 51: 1723-1725, 1973.
9. Viaje, A., Slaga, T. J., Wigler, M., and Weinstein, I. B. Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator. Cancer Res., 37: 1530-1536, 1977.
10. Kozombo, W. J., Seed, J. L., and Kensler, T. W. Inhibition by 2(3)-fert-butyl-4-hydroxyanisole and other antioxidants of epidermal omithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 43: 2555-2559, 1983.
11. Nakadate, T., Yamamoto, S., Aizu, E., and Kato, R. Effects of flavonoids and antioxidants on 12-O-tetradecanoylphorbol-13-acetate caused epidermalomithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds. Gann, 75: 214-222, 1984.
12. Smart, R. C., Huang, M.-T., Han, Z. T., Kaplan, M. C., Focella, A., and Conney, A. H. Inhibition of 12-O-tetradecanoylphorbol-l 3-acetate inductionof omithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate. Cancer Res., 47: 6633-6638, 1987.
13. Sharma, O. P. Antioxidant activity of curcumin and related compounds. Biochem. Pharmcol., 25: 1811-1812, 1976.
14. Toda, S., Miyase, T., Arichi, H., Tanizawa, H., and Takino, Y. Natural antioxidant. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chemical and Pharmaceutical Bulletin (Tokyo), 33: 1725-1728, 1985.
15. Srimal, R. C., and Dhawan, B. N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol., 25: 447-452, 1973.
16. Rao, T. S., Basu, N., and Siddiqui, H. H. Anti-inflammatory activity of curcumin analogues. Indian J. Med. Res., 75: 574-578, 1982.
17. Mukhopadhyay, A., Basu, N., Ghatak, N., and Gujral, P. K. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents and Actions, 72: 508-515, 1982.
18. Smart, R. C., Huang, M-T., and Conney, A. H. sn-l, 2-Diacylglycerols mimic the effects of 12-O-tetradecanoylphorbol-13-acetate in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis (Lond.), 7: 1865-1870, 1986.
19. Slaga, T. J., Das, S. B., Rice, J. M., and Thompson, S. Fractionation of mouse epidermal chromatin components. J. Invest. Dermatol., 63: 343-349, 1974.
20. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein determination with Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
21. Verma, A. K., and Boutwell, R. K. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res., 37: 2196-2201, 1977.
22. Fischer, S. M. Arachidonic acid metabolism and tumor promotion. In: S. M. Fischer and T. J. Slaga (eds.), Arachidonic Acid Metabolism and Tumor Promotion, pp. 21-27. The Hague: Martinus Nijhoff Publishers, 1985.
23. Higgs, G. A., and Vane, J. R. Inhibition of cyclo-oxygenase and lipoxygenase. Br. Med. Bull., 39: 265-270, 1983.
24. Lewis, J. G., and Adams, D. O. Early inflammatory changes in the skin of SENCAR and C57BL/6 mice following exposure to 12-O-tetradecanoyl phorbol-13-acetate. Carcinogenesis (Lond.), 8: 889-898, 1987.
25. Copeland, E. S. (ed.). A National Institutes of Health Workshop Report. Free radicals in promotion-a chemical pathology study section workshop. Cancer Res., 43: 5631-5637, 1983.
26. Cerutti, P. A. Prooxidant states and tumor promotion. Science (Wash. DC), 227: 375-381, 1985.
27. Slaga, T. J., Solanki, V., and Logani, M. Studies on the mechanism of action of antitumor promoting agents: Suggestive evidence for the involvement of free radicals in promotion. In: O. F. Nygaard and M. G. Simic (eds.), Radioprotectors and Anticarcinogens, pp. 471-485. New York: Academic Press, 1983.
28. Slaga, T. J., Klein-Szanto, A. J. P., Triplett, L. L., and Yotti, L. P. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radicalgenerating compound. Science (Wash. DC), 213: 1023-1025, 1981.
29. Klein-Szanto, A. J. P., and Slaga, T. J. Effects of peroxides on rodent skin: Epidermal hyperplasia and tumor promotion. J. Invest. Dermatol., 79: 30-34, 1982.
30. Bresnick, E., Bailey, G., Bonney, R. J., and Wightman, P. Phospholipase activity in skinafter application of phorbol esters and 3-methylcholanthrene. Carcinogenesis (Lond.), 2: 1119-1122, 1981.
31. Bresnick, E., Meunier. P., and Lamden, M. Epidermal prostaglandins after topical application of a tumor promoter. Cancer Lett., 7: 121-125, 1979.
32. Ashendel, C. L., and Boutwell, R. K. Prostaglandin E and F levels in mouse epidermis are increased by tumor-promoting phorbol esters. Biochem. Biophys. Res. Commun., 90: 623-627, 1979.
33. Ziboh, V. A. Arachidonic acid metabolism in the skin. In: S. M. Fischer and T. J. Slaga (eds.), Arachidonic Acid Metabolism and Tumor Promotion, pp. 6-20. The Hague: Martinus Nijhoff Publishers, 1985.
34. Egner, P. A., and Kensler, T. W. Effects of a biomimetic Superoxide dismutase on complete and multistage Carcinogenesis in mouse skin. Carcinogenesis (Lond.), 8: 1167-1172, 1985.
35. Kensler, T. W., Bush, D. M., and Kozumbo, W. J. Inhibition of tumor promotion by a biomimetic Superoxide dismutase. Science (Wash. DC), 227: 75-77, 1983.
36. Shamberger, R. J. Increase of peroxidation in Carcinogenesis. J. Natl. Cancer Inst., 48: 1491-1497, 1972.
37. Kalo, R., Nakadate, T., Yamamoto, S., and Sugimura, T. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: Possible involvement of lipoxygenase inhibition. Carcinogenesis (Lond.), 4: 1301-1305, 1983.
38. Nakadate, T., Yamamoto, S., Ishii, M., and Kato, R. Inhibition of 12-Otetradecanoylphorbol- 13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: Possible role of product(s) of lipoxygenase pathway. Carcinogenesis (Lond.), 3: 1411-1414, 1982.
39. Perchellet. J-P., Owen, M. D., Posey, T. D., Orten, D. K., and Schneider, B. A. Inhibitory effects of glutathione level-raising agents and D-α-tocopherol on ornithine decarboxylase induction and mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis (Lond.), 6: 567-573, 1985.
40. Fischer, S. M., Mills, G. D., and Slaga, T. J. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis (Lond.), 3: 1243-1245, 1982.
41. Nakadate, T., Yamamoto, S., Ishii, M., and Kalo, R. Inhibition of 12-0-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A., inhibitors and lipoxygenase inhibitors. Cancer Res., 42: 2841-2845, 1982.
42. Nakadate, T., Aizu, E., Yamamoto, S., and Kato, R. Some properties of lipoxygenase activities in cytosol and microsomal fractions of mouse epider mal homogenate. Prostaglandins Leukotrienes Med., 21: 305-319, 1986.
43. Gschwendt, M., Furstenberger, G., Kittstein, W., Besemfelder, E., Hull, W. E., Hagedorn, H., Opferkuch, H. J., and Marks, F. Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo: Identification by H-NMR and GC-MS spectroscopy. Carcinogenesis (Lond.), 7: 449-455, 1986.
44. Fischer, S. M., Baldwin, J. K., Jasheway, D. W., Patrick, K. E., and Cameron, G. S. Phorbol ester induction of 8-lipoxygenase in inbred SENCAR (SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction. Cancer Res., 48: 658-664, 1988.
45. Higgs, G. A., Salmon, J. A., and Spayne, J. A. The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin. British Journal of Pharmacology, 74: 429-433, 1981.
46. Camp, R. O. R. Prostaglandins, hydroxyfatty acids, leukotrienes, and inflammation of the skin. Clin. Exp. Dermatol., 7: 435-444, 1982.
47. Chang, J., Carlson, R. P., O'Neill-Davis, L., Lamb, B., Sharma, R. N., and Lewis, A. J. Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis. Inflammation, 10: 205-214, 1986.
48. Hamberg, M., and Samuelsson, B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. USA, 71: 3400-3404, 1974.
49. 2a in epidermis of psoriasis. Proc. Natl. Acad. Sci. USA, 72: 5130-5134, 1975.
50. Gryglewski, R. J. Effects of antiinflammatory steroids on arachidonate cascade. In: G. Weissman, B. Samuelsson, and R. Paoletti (eds.), Advances in Inflammation Research, Vol. 1, pp. 505-513. New York: Raven Press, 1979.
51. Fischer, S. M., and Adams, L. M. Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism. Cancer Res., 45: 3130-3136, 1985.
52. Niedel, J. E., Kuhn, L. J., and Vandenbank, G. R. Phorbol diester receptor copurifies with protein kinase C. Proc. Natl. Acad. Sci. USA, 80: 36-40, 1983.
53. Ravindranath, V., and Chandrasekhara, N. Absorption and tissue distribution of curcumin in rats. Toxicology, 16: 259-265, 1980.
54. Wahlstrom, B., and Blennow, G. A study on the fate of curcumin in the rat. Acta Pharmacol. Toxicol., 43: 86-92, 1978.
55. Ravindranath, V., and Chandrasekhara, N. Metabolism of curcumin-studies with [3H]curcumin. Toxicology, 22: 337-344, 1982.
56. Bille, N., Larsen, J. C., Hansen, E. V., and Wurtzen, G. Subchronic oral toxicity of turmeric oleoresin in pigs. Food Chem. Toxicol., 23: 967-973, 1985.
57. Hirose, M., Masuda, A., Imaida, K., Kagawa, M., Tsuda, H., and Ito, N. Induction of forestomach lesions in rats by oral administrations of naturally occurring antioxidants for four weeks. Jpn. J. Cancer Res. (Gann), 78: 317-321, 1987.
58. Goodpasture, C. E., and Arrighi, F. E. Effects of food seasonings on the cell cycle and chromosome morphology of mammalian cells in vitro with special reference to turmeric. Food Cosmet. Toxicol., 14: 9-14, 1976.
59. Abraham, S., Abraham, S. K., and Radhamony, G. Mutagenic potential of the condiments, ginger and turmeric, Cytologia (Tokyo), 41: 591-595, 1976.
60. Vijayalaxmi. Genetic effects of turmeric and curcumin in mice and rats. Mutat.Res., 79: 125-132, 1980.
61. Abraham, S. K., and Kesavan, P. C. Genotoxicity of garlic, turmeric and asafoetida in mice. Mutat.Res., 136: 85-88, 1984.
62. Nagabhushan, M., and Bhide, S. V. Nonmutagenicity of curcumin and its antimutagenic action versus chili and capsaicin. Nutr. Cancer, 8: 201-210, 1986.
63. Jensen, N. J. Lack of mutagenic effect of turmeric oleoresin and curcumin in the Salmonella/mammalian microsome test. Mutat. Res., 105: 393-396, 1982.
64. Kuttan, R., Bhanumathy, P., Ninnala, K., and George, M. C. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett., 29: 197-202, 1985.
65. Ramaprasad, C., and Sirsi, M. Indian medicinal plants. Curcuma longa in vitro antibacterial activity of curcumin and the essential oil. J. Sei. Ind. Res. (India), 156: 239-241, 1956.
66. Nagabhushan, M., Amonkar, A. J., and Bhide, S. V. In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem. Toxicol., 25: 545-547, 1987.